Everything Thomas Kluz said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Kluz: Financial returns are easier to generate than strategic corporate value
“I think it's easier to generate cash on cash returns purely off good investments than it is to do financial returns. And find strategic value in companies.”
Kluz: Niterra Ventures does not require business unit alignment for deals
“So because our job is to drive new core assets which are effectively non-core, we don't need business unit alignment. But we do need a there on how is this going to create a new revenue stream for Natera in the future.”
Kluz: Unique tech without paying customers is a project, not a business
“If I don't see evidence that people are paying you money consistently and repeatedly, right? I'm going to have a hard time believing that you're doing something That maybe you're doing something no one else can do, but if no one's paying you for it, that's not…”
Kluz: 3:1 LTV-to-CAC ratio is the diligence sweet spot
“I think three to one LTV to CAC seems to be kind of a sweet spot. I, that's kind of sometimes aspirational. A few of our portfolio companies have seen six to one, which is, I think outstanding. But that's the general sort of benchmark that we look for.”
Kluz: Advanced wound care is woefully underfunded in healthcare
“On the healthcare side we were very active in advanced wound care. This is just an area that we're, we think is woefully underfunded.”
Kluz: Career investors often forget founders have businesses to run
“I think when, you know, investors, sometimes life, lifetime investors never been on the operational side, I've noticed tend to kind of lose sight what the operator's kind of going through, right? The operator has, You know, day to day responsibility for the bu…”
Kluz: Niterra generates over $1B in annual free cash flow
“You know, Natera as a mothership generates about a billion plus in free cashflow every year. It's a very healthy business, very high margin business. Doing record earnings per share at this juncture and continues to get better.”
Kluz: Qualcomm Ventures backed Zoom and Waze to track 4G and 5G
“So, you know, made investments in things like zoom or ways at Qualcomm, which weren't my deals, but they were deals that were intended to be, Hey, let's keep our eyes and ears on four G and five G evolution.”
Kluz: Niterra evaluates authentication startup to combat counterfeit spark plugs
“I'm actually working on an authentication play right now. So there's a company that's in the authentication space, right? So authenticating so it's real-time visibility of product. And making sure that it's authentic, right? And making sure it was manufactured…”
Kluz: Niterra Ventures invested in Swift Navigation for precision vehicle tracking
“So we most recently made an investment in a company called swift navigation. This is centimeter level precision location tracking for a vehicle.”
Kluz: Niterra Ventures invested in tire monitoring startup Revo
“We also invested in another company called Revo, which is a tire pressure monitoring system.”
Kluz: Niterra Ventures invested in cold plasma startup Neoplast Med
“So we invested in a company called neoplast medical, which is a cold plasma based medical device uses inert gases to produce cold plasma and sanitizes wounds and reduces healing time”
Kluz: Niterra Ventures invested in synthetic skin startup Imbed Biosciences
“And then kind of connected to that, we invested in another company in the advanced wound care space called Embed Biosciences. That's a synthetic skin that gets applied to wounds. It's really interesting. The FDA approved for two indications.”